MeSH Browser

MeSH Supplementary: ocaratuzumab
Unique ID: C550337
RDF Unique Identifier: http://id.nlm.nih.gov/mesh/C550337
Entry Term(s): AME 133; AME-133; AME-133V; AME133; LY 2469298; LY-2469298; LY2469298
Registry Numbers: NTY9893GD0
Previous Indexing: *ANTIBODIES, MONOCLONAL (2010-2015)
Heading Mapped to: *Antibodies, Monoclonal, Humanized
Frequency: 5
Note: an anti-CD20 antibody for treatment of cancer in phase I/II clinical trials (2010)
Source: Semin Hematol 2010 Apr;47(2):199-210
Date of Entry: 2010/06/27
Revision Date: 2019/10/31

Concept UI: M0547613
Terms: AME 133 Preferred Term
Term UI T773228
Date06/27/2010
LexicalTag LAB
ThesaurusID NLM (2010); AME-133
Term UI T773229
Date06/27/2010
LexicalTag LAB
ThesaurusID NLM (2010); AME133
Term UI T773230
Date06/27/2010
LexicalTag LAB
ThesaurusID NLM (2010); AME-133V
Term UI T000966376
Date08/23/2019
LexicalTag LAB
ThesaurusID NLM (2020)

ocaratuzumab MeSH Supplementary Concept Data 2024